Nearly 50% of elderly patients undergoing surgical aortic valve replacement (SAVR) receive concomitant procedures, with those requiring combined valve and coronary interventions facing 5-fold higher 30-day mortality and dramatically worse long-term outcomes, according to a comprehensive Medicare database analysis.